Bannerji R - Search Results

1

Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity.

Gansbacher B, Zier K, Daniels B, Cronin K, Bannerji R, Gilboa E. Gansbacher B, et al. Among authors: bannerji r. J Exp Med. 1990 Oct 1;172(4):1217-24. doi: 10.1084/jem.172.4.1217. J Exp Med. 1990. PMID: 2212951 Free PMC article.

2

Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity.

Gansbacher B, Bannerji R, Daniels B, Zier K, Cronin K, Gilboa E. Gansbacher B, et al. Among authors: bannerji r. Cancer Res. 1990 Dec 15;50(24):7820-5. Cancer Res. 1990. PMID: 2123742

3

Immunotherapy of bladder cancer with cytokine gene-modified tumor vaccines.

Saito S, Bannerji R, Gansbacher B, Rosenthal FM, Romanenko P, Heston WD, Fair WR, Gilboa E. Saito S, et al. Among authors: bannerji r. Cancer Res. 1994 Jul 1;54(13):3516-20. Cancer Res. 1994. PMID: 8012975

4

Augmentation of antitumor immunity by tumor cells transduced with a retroviral vector carrying the interleukin-2 and interferon-gamma cDNAs.

Rosenthal FM, Cronin K, Bannerji R, Golde DW, Gansbacher B. Rosenthal FM, et al. Among authors: bannerji r. Blood. 1994 Mar 1;83(5):1289-98. Blood. 1994. PMID: 8118032 Free article.

5

Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines.

Vieweg J, Rosenthal FM, Bannerji R, Heston WD, Fair WR, Gansbacher B, Gilboa E. Vieweg J, et al. Among authors: bannerji r. Cancer Res. 1994 Apr 1;54(7):1760-5. Cancer Res. 1994. PMID: 8137291

6

Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells.

Connor J, Bannerji R, Saito S, Heston W, Fair W, Gilboa E. Connor J, et al. Among authors: bannerji r. J Exp Med. 1993 Apr 1;177(4):1127-34. doi: 10.1084/jem.177.4.1127. J Exp Med. 1993. PMID: 8459207 Free PMC article.

7

The role of IL-2 secreted from genetically modified tumor cells in the establishment of antitumor immunity.

Bannerji R, Arroyo CD, Cordon-Cardo C, Gilboa E. Bannerji R, et al. J Immunol. 1994 Mar 1;152(5):2324-32. J Immunol. 1994. PMID: 7907636

8

Anti-metastatic vaccination of tumor-bearing mice with IL-2-gene-inserted tumor cells.

Porgador A, Gansbacher B, Bannerji R, Tzehoval E, Gilboa E, Feldman M, Eisenbach L. Porgador A, et al. Among authors: bannerji r. Int J Cancer. 1993 Feb 1;53(3):471-7. doi: 10.1002/ijc.2910530320. Int J Cancer. 1993. PMID: 8428800

9

Antimetastatic vaccination of tumor-bearing mice with two types of IFN-gamma gene-inserted tumor cells.

Porgador A, Bannerji R, Watanabe Y, Feldman M, Gilboa E, Eisenbach L. Porgador A, et al. Among authors: bannerji r. J Immunol. 1993 Feb 15;150(4):1458-70. J Immunol. 1993. PMID: 8432988

10

Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort.

Tam CS, Allan JN, Siddiqi T, Kipps TJ, Jacobs R, Opat S, Barr PM, Tedeschi A, Trentin L, Bannerji R, Jackson S, Kuss BJ, Moreno C, Szafer-Glusman E, Russell K, Zhou C, Ninomoto J, Dean JP, Wierda WG, Ghia P. Tam CS, et al. Among authors: bannerji r. Blood. 2022 Jun 2;139(22):3278-3289. doi: 10.1182/blood.2021014488. Blood. 2022. PMID: 35196370 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters